Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2026 Filed Sep 9, 2026 20:58 UTC |
Ory Daniel ScottEVP, Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 950,000 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0002149618-26-000006 · wk-form4_1788987497.xml · derivative · entry 1 Ory Daniel Scott · CIK 0002149618 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 950,000 Underlying: Common Stock · 950,000 shares Expires 2036-09-07 F1 · derivative.exercise_date: This option was granted on September 8, 2026 and is scheduled to vest over four years, with 25% of the shares to vest on October 15, 2027 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 15, 2030. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:27 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 709 | $3.04 | $2,153.37 |
DisclosureSEC source: 0001985604-26-000003 · wk-form4_1788553659.xml · nonDerivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,660 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $3.0050 to $3.0372. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:25 UTC |
Parison AmySVP, Chief Financial Officer
|
SaleCommon Stock | 453 | $3.04 | $1,375.85 |
DisclosureSEC source: 0002063082-26-000006 · wk-form4_1788553522.xml · nonDerivative · entry 1 Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,839 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:22 UTC |
O'Neill Gilmore NeilDirector · CEO
|
SaleCommon Stock | 5,124 | $3.04 | $15,562.61 |
DisclosureSEC source: 0001742084-26-000003 · wk-form4_1788553359.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 243,189 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $3.0050 to $3.0372. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2026 Filed Aug 7, 2026 21:16 UTC |
Ellinor Patrick Thomas IIDirector
|
GrantStock Option (right to buy) · Derivative | 103,400 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0002137699-26-000004 · wk-form4_1786137389.xml · derivative · entry 1 Ellinor Patrick Thomas II · CIK 0002137699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,400 Underlying: Common Stock · 103,400 shares Expires 2036-08-05 F1 · derivative.exercise_date: This option was granted on August 6, 2026 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on August 6, 2027 through August 6, 2029. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:07 UTC |
Parison AmySVP, Chief Financial Officer
|
SaleCommon Stock | 678 | $2.58 | $1,749.24 |
DisclosureSEC source: 0002063082-26-000003 · wk-form4_1785960474.xml · nonDerivative · entry 1 Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,292 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 1, 2026. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| July 28, 2026 Filed Jul 29, 2026 20:51 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 4,928 | $2.67 | $13,157.76 |
DisclosureSEC source: 0001650664-26-000076 · wk-form4_1785358259.xml · nonDerivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,369 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2026. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:28 UTC |
Levy Elliott M.Director
|
GrantStock Option (right to buy) · Derivative | 51,700 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001650664-26-000068 · wk-form4_1782160133.xml · derivative · entry 1 Levy Elliott M. · CIK 0001858745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,700 Underlying: Common Stock · 51,700 shares Expires 2036-06-16 F1 · derivative.exercise_date: This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:30 UTC |
Hirsch AndrewDirector
|
GrantStock Option (right to buy) · Derivative | 51,700 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001650664-26-000070 · wk-form4_1782160207.xml · derivative · entry 1 Hirsch Andrew · CIK 0001586707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,700 Underlying: Common Stock · 51,700 shares Expires 2036-06-16 F1 · derivative.exercise_date: This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:30 UTC |
Hopfield JessicaDirector
|
GrantStock Option (right to buy) · Derivative | 51,700 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001650664-26-000071 · wk-form4_1782160247.xml · derivative · entry 1 Hopfield Jessica · CIK 0001648715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,700 Underlying: Common Stock · 51,700 shares Expires 2036-06-16 F1 · derivative.exercise_date: This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:29 UTC |
Scadden DavidDirector
|
GrantStock Option (right to buy) · Derivative | 51,700 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001650664-26-000069 · wk-form4_1782160170.xml · derivative · entry 1 Scadden David · CIK 0001707715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,700 Underlying: Common Stock · 51,700 shares Expires 2036-06-16 F1 · derivative.exercise_date: This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:31 UTC |
Connaughton BernadetteDirector
|
GrantStock Option (right to buy) · Derivative | 51,700 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001650664-26-000072 · wk-form4_1782160274.xml · derivative · entry 1 Connaughton Bernadette · CIK 0001662521 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,700 Underlying: Common Stock · 51,700 shares Expires 2036-06-16 F1 · derivative.exercise_date: This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:33 UTC |
Parison AmySVP, Chief Financial Officer
|
SaleCommon Stock | 464 | $2.70 | $1,253.26 |
DisclosureSEC source: 0001650664-26-000057 · wk-form4_1780691609.xml · nonDerivative · entry 1 Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,970 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7049. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:32 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 731 | $2.70 | $1,974.50 |
DisclosureSEC source: 0001650664-26-000055 · wk-form4_1780691552.xml · nonDerivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,297 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7050. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:33 UTC |
O'Neill Gilmore NeilDirector · CEO
|
SaleCommon Stock | 15,380 | $2.70 | $41,542.92 |
DisclosureSEC source: 0001650664-26-000056 · wk-form4_1780691579.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 248,313 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7250. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:34 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
GrantStock Option (right to buy) · Derivative | 292,856 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001650664-26-000021 · wk-form4_1773693286.xml · derivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 292,856 Underlying: Common Stock · 292,856 shares Expires 2036-03-11 F1 · derivative.exercise_date: This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:37 UTC |
O'Neill Gilmore NeilDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 1,015,200 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001650664-26-000023 · wk-form4_1773693426.xml · derivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,015,200 Underlying: Common Stock · 1,015,200 shares Expires 2036-03-11 F1 · derivative.exercise_date: This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:35 UTC |
Parison AmySVP, Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 292,856 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001650664-26-000022 · wk-form4_1773693348.xml · derivative · entry 1 Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 292,856 Underlying: Common Stock · 292,856 shares Expires 2036-03-11 F1 · derivative.exercise_date: This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:56 UTC |
O'Neill Gilmore NeilDirector · CEO
|
SaleCommon Stock | 5,394 | $2.02 | $10,894.26 |
DisclosureSEC source: 0001650664-26-000009 · wk-form4_1772661358.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 263,693 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.0050 to $2.0204 The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:49 UTC |
Parison AmySVP, Chief Financial Officer
|
SaleCommon Stock | 474 | $2.02 | $957.48 |
DisclosureSEC source: 0001650664-26-000007 · wk-form4_1772660958.xml · nonDerivative · entry 1 Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,434 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.0050 to $2.0204. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:48 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 749 | $2.02 | $1,512.68 |
DisclosureSEC source: 0001650664-26-000006 · wk-form4_1772660918.xml · nonDerivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,028 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.0041 to $2.0204. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:39 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 713 | $2.15 | $1,535.16 |
DisclosureSEC source: 0001650664-25-000163 · wk-form4_1764884348.xml · nonDerivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,777 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:38 UTC |
O'Neill Gilmore NeilDirector · CEO
|
SaleCommon Stock | 5,603 | $2.15 | $12,063.82 |
DisclosureSEC source: 0001650664-25-000162 · wk-form4_1764884318.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,087 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:38 UTC |
Parison AmySVP, Chief Financial Officer
|
SaleCommon Stock | 461 | $2.15 | $992.58 |
DisclosureSEC source: 0001650664-25-000161 · wk-form4_1764884284.xml · nonDerivative · entry 1 Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,908 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 20:20 UTC |
Parison AmySVP, Chief Financial Officer
|
SaleCommon Stock | 458 | $2.60 | $1,189.01 |
DisclosureSEC source: 0001650664-25-000142 · wk-form4_1757017244.xml · nonDerivative · entry 1 Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,369 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 20:21 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 710 | $2.60 | $1,843.23 |
DisclosureSEC source: 0001650664-25-000143 · wk-form4_1757017284.xml · nonDerivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,490 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person. F2 · balance_after: The amount of securities beneficially owned following the reported transaction includes 5,802 shares acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 20:20 UTC |
O'Neill Gilmore NeilDirector · CEO
|
SaleCommon Stock | 5,592 | $2.60 | $14,517.39 |
DisclosureSEC source: 0001650664-25-000141 · wk-form4_1757017197.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 274,690 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:28 UTC |
Parison AmySVP, Chief Financial Officer
|
SaleCommon Stock | 679 | $2.58 | $1,751.82 |
DisclosureSEC source: 0001650664-25-000118 · wk-form4_1754684878.xml · nonDerivative · entry 1 Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,827 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 6, 2025. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 20:49 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 5,121 | $2.49 | $12,756.92 |
DisclosureSEC source: 0001650664-25-000113 · wk-form4_1754340586.xml · nonDerivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,398 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2025. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:18 UTC |
Levy Elliott M.Director
|
GrantStock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001650664-25-000101 · wk-form4_1749586723.xml · derivative · entry 1 Levy Elliott M. · CIK 0001858745 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:18 UTC |
Hirsch AndrewDirector
|
GrantStock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001650664-25-000099 · wk-form4_1749586673.xml · derivative · entry 1 Hirsch Andrew · CIK 0001586707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:19 UTC |
Hopfield JessicaDirector
|
GrantStock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001650664-25-000103 · wk-form4_1749586773.xml · derivative · entry 1 Hopfield Jessica · CIK 0001648715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:19 UTC |
Scadden DavidDirector
|
GrantStock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001650664-25-000102 · wk-form4_1749586749.xml · derivative · entry 1 Scadden David · CIK 0001707715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:18 UTC |
Connaughton BernadetteDirector
|
GrantStock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001650664-25-000100 · wk-form4_1749586697.xml · derivative · entry 1 Connaughton Bernadette · CIK 0001662521 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 22:39 UTC |
Parison AmySVP, Chief Financial Officer
|
SaleCommon Stock | 446 | $1.72 | $768.90 |
DisclosureSEC source: 0001650664-25-000093 · wk-form4_1749076755.xml · nonDerivative · entry 1 Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,506 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person F2 · price: This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7522. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 22:37 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 726 | $1.72 | $1,251.84 |
DisclosureSEC source: 0001650664-25-000091 · wk-form4_1749076666.xml · nonDerivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,519 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7522. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 22:36 UTC |
O'Neill Gilmore NeilDirector · CEO
|
SaleCommon Stock | 15,192 | $1.72 | $26,195.57 |
DisclosureSEC source: 0001650664-25-000089 · wk-form4_1749076593.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 280,282 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7566 . The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 08, 2025 Filed Apr 8, 2025 20:29 UTC |
Parison AmySVP, Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 34,672 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001650664-25-000052 · wk-form4_1744144175.xml · derivative · entry 1 Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,672 Underlying: Common Stock · 34,672 shares Expires 2035-04-07 F1 · derivative.exercise_date: This option was granted on April 8, 2025 and is scheduled to vest over four years, with 25% of the shares to vest on April 8, 2026 and the remaining 75% of the shares scheduled to vest in equal monthly monthly installments thereafter through April 8, 2029. Read SEC document |
| March 08, 2025 Filed Mar 27, 2025 20:41 UTC |
Lucera ErickEVP, CHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001650664-25-000040 · wk-form4_1743108110.xml · derivative · entry 2 Lucera Erick · CIK 0001697616 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2035-03-07 F2 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026. Read SEC document |
| March 08, 2025 Filed Mar 27, 2025 20:41 UTC |
Lucera ErickEVP, CHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 275,100 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001650664-25-000040 · wk-form4_1743108110.xml · derivative · entry 1 Lucera Erick · CIK 0001697616 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,100 Underlying: Common Stock · 275,100 shares Expires 2035-03-07 F1 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029. Read SEC document |
| March 08, 2025 Filed Mar 27, 2025 20:37 UTC |
O'Neill Gilmore NeilDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001650664-25-000037 · wk-form4_1743107853.xml · derivative · entry 2 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2035-03-07 F2 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026. Read SEC document |
| March 08, 2025 Filed Mar 27, 2025 20:37 UTC |
O'Neill Gilmore NeilDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 828,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001650664-25-000037 · wk-form4_1743107853.xml · derivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 828,000 Underlying: Common Stock · 828,000 shares Expires 2035-03-07 F1 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029. Read SEC document |
| March 08, 2025 Filed Mar 27, 2025 20:33 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001650664-25-000034 · wk-form4_1743107610.xml · derivative · entry 2 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2035-03-07 F2 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026. Read SEC document |
| March 08, 2025 Filed Mar 27, 2025 20:33 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
GrantStock Option (right to buy) · Derivative | 275,100 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001650664-25-000034 · wk-form4_1743107610.xml · derivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,100 Underlying: Common Stock · 275,100 shares Expires 2035-03-07 F1 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:44 UTC |
Lucera ErickEVP, CHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 4,109 | $1.71 | $7,029.68 |
DisclosureSEC source: 0001650664-25-000027 · wk-form4_1741211041.xml · nonDerivative · entry 1 Lucera Erick · CIK 0001697616 · EVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,720 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 12, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 3, 2025. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $1.7107 to $1.7150 . The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:43 UTC |
O'Neill Gilmore NeilDirector · CEO
|
SaleCommon Stock | 16,632 | $1.71 | $28,452.36 |
DisclosureSEC source: 0001650664-25-000026 · wk-form4_1741210979.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 295,474 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 3, 2025. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $1.7107 to $1.7125 . The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:41 UTC |
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
|
SaleCommon Stock | 2,891 | $1.71 | $4,945.63 |
DisclosureSEC source: 0001650664-25-000025 · wk-form4_1741210903.xml · nonDerivative · entry 1 Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,245 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2025. The sale does not represent a discretionary trade by the Reporting Person. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 21:40 UTC |
O'Neill Gilmore NeilDirector · CEO
|
SaleCommon Stock | 1,618 | $2.08 | $3,361.23 |
DisclosureSEC source: 0001650664-24-000126 · wk-form4_1733434825.xml · nonDerivative · entry 1 O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,106 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2024. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.0550 to $2.0783. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 21:37 UTC |
Mei BaisongEVP, CHIEF MEDICAL OFFICER
|
SaleCommon Stock | 541 | $2.08 | $1,123.77 |
DisclosureSEC source: 0001650664-24-000124 · wk-form4_1733434638.xml · nonDerivative · entry 1 Mei Baisong · CIK 0001938499 · EVP, CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,354 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2024. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $2.0507 to $2.0783. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 04, 2024 Filed Sep 6, 2024 20:20 UTC |
Mei BaisongEVP, CHIEF MEDICAL OFFICER
|
SaleCommon Stock | 518 | $3.42 | $1,773.99 |
DisclosureSEC source: 0001650664-24-000105 · wk-form4_1725654028.xml · nonDerivative · entry 1 Mei Baisong · CIK 0001938499 · EVP, CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,895 F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2024. The sale does not represent a discretionary trade by the Reporting Person. F2 · price: This transaction was executed in multiple trades at prices ranging from $3.4246 to $3.4501. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.